^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    cemacabtagene ansegedleucel (ALLO-501A)

    i
    Company:
    Allogene Therap, Cellectis
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs: